186 株诺卡氏菌属对 20 种抗菌药物的敏感性。
Susceptibility of 186 Nocardia sp. isolates to 20 antimicrobial agents.
机构信息
Servicio de Microbiología-Instituto Biodonostia, Hospital Donostia, San Sebastián, Spain.
出版信息
Antimicrob Agents Chemother. 2011 Jun;55(6):2995-8. doi: 10.1128/AAC.01279-10. Epub 2011 Mar 14.
Abstract
This study determined the antimicrobial susceptibilities of 186 clinical isolates of Nocardia spp. isolated in Gipuzkoa, northern Spain, between 1998 and 2009. Most isolates were recovered from respiratory samples, Nocardia nova, N. farcinica, N. cyriacigeorgica, N. abscessus, and N. carnea being the species most frequently isolated. Linezolid and amikacin were the only two antimicrobials to which all isolates were susceptible. The majority of N. flavorosea, N. carnea, and N. farcinica isolates were trimethoprim-sulfamethoxazole resistant.
摘要
本研究确定了 1998 年至 2009 年间在西班牙北部吉普斯夸（Gipuzkoa）分离的 186 株诺卡氏菌属临床分离株的抗菌药敏性。大多数分离株来自呼吸道样本，最常分离到的菌种为新星诺卡氏菌（N. nova）、星形诺卡氏菌（N. farcinica）、细弱诺卡氏菌（N. cyriacigeorgica）、脓肿诺卡氏菌（N. abscessus）和肉色诺卡氏菌（N. carnea）。利奈唑胺和阿米卡星是所有分离株均敏感的仅有的两种抗菌药物。大多数芬芳诺卡氏菌（N. flavorosea）、肉色诺卡氏菌和星形诺卡氏菌分离株对甲氧苄啶-磺胺甲恶唑耐药。
相似文献
1
Susceptibility of 186 Nocardia sp. isolates to 20 antimicrobial agents.186 株诺卡氏菌属对 20 种抗菌药物的敏感性。
Antimicrob Agents Chemother. 2011 Jun;55(6):2995-8. doi: 10.1128/AAC.01279-10. Epub 2011 Mar 14.
2
Epidemiology and susceptibility to antimicrobial agents of the main Nocardia species in Spain.西班牙主要诺卡氏菌属菌种的流行病学及对抗菌药物的敏感性
J Antimicrob Chemother. 2017 Mar 1;72(3):754-761. doi: 10.1093/jac/dkw489.
3
Antimicrobial susceptibility among clinical Nocardia species identified by multilocus sequence analysis.通过多位点序列分析鉴定的临床诺卡氏菌属菌种的抗菌药敏性。
Antimicrob Agents Chemother. 2015 Jan;59(1):269-75. doi: 10.1128/AAC.02770-14. Epub 2014 Oct 27.
4
Antimicrobial susceptibility profiles and species distribution of medically relevant Nocardia species: Results from a large tertiary laboratory in Australia.澳大利亚一家大型三级实验室的医学相关诺卡氏菌属的药敏谱和种属分布。
J Glob Antimicrob Resist. 2020 Mar;20:110-117. doi: 10.1016/j.jgar.2019.06.018. Epub 2019 Aug 7.
5
[Antimicrobial susceptibilities of clinical Nocardia isolates identified by 16S rRNA gene sequence analysis].[通过16S rRNA基因序列分析鉴定的临床诺卡菌分离株的抗菌药敏性]
Mikrobiyol Bul. 2016 Jan;50(1):11-20. doi: 10.5578/mb.10639.
6
Identification and antimicrobial susceptibility of referred isolates in Victoria, Australia 2009-2019.澳大利亚维多利亚州 2009-2019 年送检分离株的鉴定及药敏试验结果。
J Med Microbiol. 2022 Aug;71(8). doi: 10.1099/jmm.0.001581.
7
Susceptibility profiles of Nocardia isolates based on current taxonomy.基于当前分类学的诺卡氏菌属分离株的药敏谱。
Antimicrob Agents Chemother. 2014;58(2):795-800. doi: 10.1128/AAC.01531-13. Epub 2013 Nov 18.
8
MLSA phylogeny and antimicrobial susceptibility of clinical Nocardia isolates: a multicenter retrospective study in China.MLSA 系统发育分析和临床诺卡菌分离株的药敏结果：中国多中心回顾性研究。
BMC Microbiol. 2021 Dec 13;21(1):342. doi: 10.1186/s12866-021-02412-x.
9
Clinical features, identification, antimicrobial resistance patterns of Nocardia species in China: 2009-2017.中国诺卡氏菌属的临床特征、鉴定及抗菌药物耐药模式：2009-2017 年。
Diagn Microbiol Infect Dis. 2019 Jun;94(2):165-172. doi: 10.1016/j.diagmicrobio.2018.12.007. Epub 2018 Dec 29.
10
Determination of antimicrobial susceptibility patterns of Nocardia spp. from clinical specimens by Etest.采用Etest法测定临床标本中诺卡氏菌属的抗菌药敏模式。
Clin Microbiol Infect. 2006 Sep;12(9):905-12. doi: 10.1111/j.1469-0691.2006.01460.x.
引用本文的文献
1
Successful Treatment of Brain Abscess Caused by with Combination Therapy Despite Discrepancies in In Vitro Results: A Case Report and Review of Diagnostic and Therapeutic Challenges.尽管体外结果存在差异，但联合治疗成功治愈由[病原体未提及]引起的脑脓肿：一例病例报告及诊断和治疗挑战的综述
Microorganisms. 2025 Jun 30;13(7):1536. doi: 10.3390/microorganisms13071536.
2
A rare case of multiple brain abscesses caused by Nocardia abscessus co-infection with tuberculous meningitis in an immunocompetent patient.一名免疫功能正常的患者发生罕见的由脓肿诺卡菌与结核性脑膜炎共同感染引起的多发性脑脓肿病例。
BMC Infect Dis. 2025 May 13;25(1):694. doi: 10.1186/s12879-025-11056-5.
3
Liver cirrhosis complicated with pulmonary Nocardia infection: A case report and literature review.肝硬化合并肺部诺卡菌感染：一例报告及文献复习
Medicine (Baltimore). 2024 Dec 6;103(49):e40054. doi: 10.1097/MD.0000000000040054.
4
Nocardia farcinica pneumonia complicated by pneumocystis jiroveci infection in children with Neuromyelitis Optica Spectrum Disorders: a case report and literature review.视神经脊髓炎谱系障碍患儿中，鼻疽诺卡菌肺炎合并耶氏肺孢子菌感染：一例报告及文献复习
Ital J Pediatr. 2024 Dec 2;50(1):255. doi: 10.1186/s13052-024-01827-2.
5
Case report: Metagenomic next-generation sequencing for the diagnosis of rare infection in a patient with immune thrombocytopenia.病例报告：宏基因组下一代测序用于诊断免疫性血小板减少症患者的罕见感染
Front Med (Lausanne). 2024 Nov 6;11:1425655. doi: 10.3389/fmed.2024.1425655. eCollection 2024.
6
Secreted protein NFA47630 from Nocardia farcinica IFM10152 induces immunoprotective effects in mice.来自星形诺卡菌IFM10152的分泌蛋白NFA47630在小鼠中诱导免疫保护作用。
Trop Dis Travel Med Vaccines. 2024 Oct 15;10(1):21. doi: 10.1186/s40794-024-00229-w.
7
Application of MALDI-TOF mass spectrometry for identification of Nocardia species.基质辅助激光解吸电离飞行时间质谱在诺卡氏菌属菌种鉴定中的应用。
BMC Microbiol. 2024 Sep 20;24(1):358. doi: 10.1186/s12866-024-03483-2.
8
Disseminated Nocardia nova in a child with relapsed acute lymphoblastic leukemia: a case report.播散性新型奴卡菌感染致复发急性淋巴细胞白血病患儿 1 例报告
BMC Infect Dis. 2024 Feb 1;24(1):154. doi: 10.1186/s12879-023-08895-5.
9
Rare occurrence of pulmonary coinfection involving Aspergillus fumigatus and Nocardia cyriacigeorgica in immunocompetent patients based on NGS: A case report and literature review.基于高通量测序的免疫功能正常患者中罕见的烟曲霉和触须诺卡菌肺部合并感染：病例报告及文献复习。
Medicine (Baltimore). 2023 Dec 22;102(51):e36692. doi: 10.1097/MD.0000000000036692.
10
First Report of Clivus Osteomyelitis Caused by Nocardia veterana in a Lung Transplant Recipient.肺移植受者中由退伍军人诺卡菌引起的斜坡骨髓炎的首例报告。
Cureus. 2023 Mar 21;15(3):e36487. doi: 10.7759/cureus.36487. eCollection 2023 Mar.
本文引用的文献
1
In vitro activity of ACH-702, a new isothiazoloquinolone, against Nocardia brasiliensis compared with econazole and the carbapenems imipenem and meropenem alone or in combination with clavulanic acid.新型异噻唑烷酮类药物 ACH-702 对巴西诺卡菌的体外活性研究，与依康唑、碳青霉烯类药物亚胺培南和美罗培南单独或联合克拉维酸比较。
Antimicrob Agents Chemother. 2010 May;54(5):2191-3. doi: 10.1128/AAC.01520-09. Epub 2010 Mar 22.
2
Comparative in vitro activities of nemonoxacin, doripenem, tigecycline and 16 other antimicrobials against Nocardia brasiliensis, Nocardia asteroides and unusual Nocardia species.奈诺沙星、多黏菌素、替加环素及其他16种抗菌药物对巴西诺卡菌、星形诺卡菌及罕见诺卡菌属菌种的体外活性比较
J Antimicrob Chemother. 2009 Jul;64(1):73-8. doi: 10.1093/jac/dkp144. Epub 2009 Apr 27.
3
Pulmonary nocardiosis: risk factors, clinical features, diagnosis and prognosis.肺诺卡菌病：危险因素、临床特征、诊断与预后
Curr Opin Pulm Med. 2008 May;14(3):219-27. doi: 10.1097/MCP.0b013e3282f85dd3.
4
Nocardia wallacei sp. nov. and Nocardia blacklockiae sp. nov., human pathogens and members of the "Nocardia transvalensis Complex".华莱士诺卡菌新种和布莱克洛克诺卡菌新种，人类病原体及“德兰士瓦诺卡菌复合体”成员
J Clin Microbiol. 2008 Apr;46(4):1178-84. doi: 10.1128/JCM.02011-07. Epub 2008 Feb 6.
5
Clinical and microbiological features of nocardiosis 1997-2003.1997 - 2003年诺卡菌病的临床和微生物学特征
J Med Microbiol. 2007 Apr;56(Pt 4):545-550. doi: 10.1099/jmm.0.46774-0.
6
In vitro activities of tigecycline and eight other antimicrobials against different Nocardia species identified by molecular methods.替加环素及其他8种抗菌药物对经分子方法鉴定的不同诺卡菌属菌种的体外活性。
Antimicrob Agents Chemother. 2007 Mar;51(3):1102-4. doi: 10.1128/AAC.01102-06. Epub 2006 Dec 28.
7
Determination of antimicrobial susceptibility patterns of Nocardia spp. from clinical specimens by Etest.采用Etest法测定临床标本中诺卡氏菌属的抗菌药敏模式。
Clin Microbiol Infect. 2006 Sep;12(9):905-12. doi: 10.1111/j.1469-0691.2006.01460.x.
8
Clinical and laboratory features of the Nocardia spp. based on current molecular taxonomy.基于当前分子分类学的诺卡氏菌属的临床和实验室特征。
Clin Microbiol Rev. 2006 Apr;19(2):259-82. doi: 10.1128/CMR.19.2.259-282.2006.
9
Nocardiosis: review of clinical and laboratory experience.诺卡菌病：临床与实验室经验综述
J Clin Microbiol. 2003 Oct;41(10):4497-501. doi: 10.1128/JCM.41.10.4497-4501.2003.
10
Infection caused by Nocardia farcinica: case report and review.马杜拉放线菌感染：病例报告与文献复习
Eur J Clin Microbiol Infect Dis. 2000 Mar;19(3):205-12. doi: 10.1007/s100960050460.
Zotero 插件